Alteration of SC35 localization by transfection reagents.


Journal

Biochimica et biophysica acta. Molecular cell research
ISSN: 1879-2596
Titre abrégé: Biochim Biophys Acta Mol Cell Res
Pays: Netherlands
ID NLM: 101731731

Informations de publication

Date de publication:
04 2020
Historique:
received: 06 09 2019
revised: 31 12 2019
accepted: 10 01 2020
pubmed: 19 1 2020
medline: 1 7 2020
entrez: 19 1 2020
Statut: ppublish

Résumé

Transfection is a powerful tool that enables introducing foreign nucleic acids into living cells in order to study the function of a gene product. Ever since the discovery of transfection many side effects or artifacts caused by transfection reagents have been reported. Here, we show that the transfection reagent, JetPRIME alters the localization of the splicing protein SC35 widely used as a nuclear speckle marker. We demonstrate that transfection of plasmids with JetPRIME leads to enlarged SC35 speckles and SC35 cytoplasmic granules. By contrast, transfection of the same plasmid with Lipofectamine 3000 does not have any effect on SC35 localization. The formation of SC35 cytoplasmic granules by JetPRIME-mediated transfection is independent of exogenous expression by plasmid and although similar in morphology they are distinct from P-bodies and stress granules. This method of transfection affected only SC35 and phosphorylated SR proteins but not the nuclear speckles. The JetPRIME-mediated transfection also showed compromised transcription in cells with enlarged SC35 speckles. Our work indicates that the use of JetPRIME alters SC35 localization and can affect gene expression and alternative splicing. Therefore, caution should be exercised when interpreting results after the use of a transient transfection system, particularly when the subject of the study is the function of a protein in the control of gene expression or mRNA splicing.

Identifiants

pubmed: 31953060
pii: S0167-4889(20)30008-2
doi: 10.1016/j.bbamcr.2020.118650
pii:
doi:

Substances chimiques

Indicators and Reagents 0
SRSF2 protein, human 147153-65-9
Serine-Arginine Splicing Factors 170974-22-8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

118650

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflict of interest.

Auteurs

Arun Prasath Damodaran (AP)

University of Rennes 1, CNRS, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, F35000 Rennes, France. Electronic address: arun-prasath.damodaran@univ-rennes1.fr.

Thibault Courthéoux (T)

University of Rennes 1, CNRS, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, F35000 Rennes, France.

Erwan Watrin (E)

University of Rennes 1, CNRS, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, F35000 Rennes, France.

Claude Prigent (C)

University of Rennes 1, CNRS, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, F35000 Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH